investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Integrating Competing Risks into the CISNET DFCI Breast Cancer Model
Ellen P Mccarthy
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ellen P Mccarthy
Beth Israel Deaconess Medical Center
Boston, United States
Related projects
Emanuele Mazzola
Risk assessment in atypical breast hyperplasia
Breast
Xiaofeng Steven Zheng
Role of Rab1 in Cell Growth and Cancer
Breast
Pathology
Jianghong Rao
An Activatable PET Tracer for Imaging PARP-1 Activity in Breast Cancer
Breast
Radiation Oncology
Franziska Michor
Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies
Breast
Len Novilla
Philippines Breast Cancer KAP Survey
Breast
Oxana G Palesh
Brief Behavioral Intervention for Insomnia During Chemotherapy
Breast
Kornelia Polyak
Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
Breast
Sandra J Lee
Analytical Investigation of Breast Cancer Progression: DCIS, Overdiagnosis
Breast
Eric Oldfield
Next generation bisphosphonates for chemo- and immuno-therapy
Breast
